1
Home
Companies

PharmAthene

PharmAthene
Leadership team

Wayne F. Pisano (Independent Director)

David J. Drutz (Independent Director)

Mitchel B. Sayare (Independent Chairman)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
50 - 100
Headquarters
Annapolis, Maryland, United States
Established
2001
Company Registration
SEC CIK number: 0001326190
Traded as
NYSEAMERICAN:PIP
Social Media
URL
www.pharmathene.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
PharmAthene is a leading biodefense company dedicated to the development and commercialization of medical countermeasures against chemical and biological threats.
History

PharmAthene was founded in 2005 and is headquartered in Annapolis, Maryland. We develop advanced vaccines, topical formulations and medical countermeasures for the prevention and treatment of lethal agents of chemical and biological warfare.

Mission
Our mission is to provide medical countermeasures against chemical and biological threats that are safe and effective for any operation.
Vision
Our vision is to be a global leader in biodefense solutions and to serve as an innovator and a trusted partner in protecting the lives of millions around the world from the effects of chemical and biological weapons.
Key Team

Mazen Noureddin (Member of Nash Scientific Advisory Board)

John M. Amatruda (Member of Obesity Scientific Advisory Board)

Rohit Loomba (Member of Nash Scientific Advisory Board)

Robert F. Kushner (Member of Obesity Scientific Advisory Board)

Michael Charlton (Member of Nash Scientific Advisory Board)

Stephen A. Harrison (Member of Nash Scientific Advisory Board)

Juan Pablo Frias (Member of Obesity Scientific Advisory Board)

Louis J. Aronne (Member of Obesity Scientific Advisory Board)

Caroline M. Apovian (Member of Obesity Scientific Advisory Board)

Donna Ryan (Member of Obesity Scientific Advisory Board)

John Petricciani (Member of Scientific Advisory Board)

Samuel Klein (Member of Obesity Scientific Advisory Board)

Daniel J. Drucker (Member of Obesity Scientific Advisory Board)

Naga Chalasani (Member of Nash Scientific Advisory Board)

Vipin K. Garg (President, CEO & Director)

John M. Gill (Independent Director)

Philip L. Hodges (Independent Director)

Klaus O. Schafer (Independent Director)

Richard James Whitley (Member of Scientific Advisory Board)

Diane Kathryn Jorkasky (Independent Director)

Recognition and Awards
PharmAthene has received numerous awards for its contributions to the biodefense community, including the National Medal of Technology and Innovation, the National Institutes of Health Grand Challenge award, and best-in-class product awards from the National Defense Industrial Association.
References

https://in.investing.com/equities/pharmathene-inc

https://www.crunchbase.com/organization/pharmathene

www.pharmathene.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

PharmAthene
Leadership team

Wayne F. Pisano (Independent Director)

David J. Drutz (Independent Director)

Mitchel B. Sayare (Independent Chairman)

Products/ Services
Biotechnology, Health Care, Medical
Number of Employees
50 - 100
Headquarters
Annapolis, Maryland, United States
Established
2001
Company Registration
SEC CIK number: 0001326190
Traded as
NYSEAMERICAN:PIP
Social Media
URL
www.pharmathene.com